Je. Dickinson et al., THE OVINE FETAL SYMPATHOADRENAL RESPONSE TO THE MATERNAL ADMINISTRATION OF METHAMPHETAMINE, American journal of obstetrics and gynecology, 170(5), 1994, pp. 1452-1457
OBJECTIVE: We hypothesized that maternally administered methamphetamin
e would alter fetal sympathoadrenal activity. STUDY DESIGN: Six chroni
cally catheterized near-term pregnant ewes received an intravenous bol
us injection of methamphetamine (1.25 mg/kg). Maternal and fetal arter
ial blood gas values, glucose, insulin, lactate, and catecholamines we
re measured in the control period and at 15, 30, 60, 90, 120, and 180
minutes after methamphetamine. RESULTS: Fetal P-O2 decreased from 21.4
+/- 1.9 mm Hg at control measurement to 15.3 +/- 3.3 mm Hg after 60 m
inutes (p < 0.05). Fetal pH declined from 7.35 +/- 0.014 at control to
7.29 +/- 0.024 after 180 minutes. Fetal plasma glucose rose from 15.3
+/- 2.4 mg/dl at control to peak at 51.2 +/- 6.8 mg/dl at 120 minutes
. Insulin levels increased from a control of 40.5 +/- 8.06 to a peak o
f 128 +/- 46 mu lU/ml at 180 minutes (p < 0.05). Lactate levels increa
sed from a baseline of 33.5 +/- 2.0 mg/dl to 92.3 +/- 22.8 mg/dl at 18
0 minutes. Fetal catecholamines rose from a baseline of 153 +/- 20.2 p
g/ml for epinephrine and 226 +/- 18.5 pg/ml for norepinephrine to maxi
mum values of 518 +/- 87.3 and 661 +/- 59.3 pg/ml at 15 minutes (p < 0
.05), declining thereafter. CONCLUSIONS: Maternal administration of me
thamphetamine is associated with a short-term increase in circulating
fetal catecholamines followed by hyperglycemia, lactacidemia, and hype
rinsulinemia. These findings suggest that the alteration of fetal symp
athoadrenal activity may contribute to the various perinatal complicat
ions associated with methamphetamine use.